B-SMART
Brain-Specific, Modular and Active RNA Therapeutics
- Description
B-SMART aims at designing and manufacturing modular nanoparticles via a quality-by-design protocol. These nanoparticles shall serve to deliver therapeutic RNAs to the brain and treat neurodegenerative diseases. B-SMART expects to arrive at a scale-able nanoparticle formulation with uniform characteristics that shows a strong pre-clinical evidence of therapeutic efficacy and is ready for clinical translation.
- Coordinator
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 66 months (January 2017 - June 2022)
- Project funding
- € 5,998,303.75
- Project partners
- 9
- Technology readiness level
- 4-7
- Project website
- http://b-smart-project.eu